Biopharmaceuticals





Biopharmaceuticals
Biotech
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Technical Analysis
Value Investing

Is GILD a bargain – or a big risk?

It seems that the only news anybody really cares about right now is the trade war. China announced yesterday that it would impose $60 billion of retaliatory tariffs against the U.S. after the Trump administration increased already imposed duties from 10% to 25% at the end of last week. That has propelled the market to […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Affimed N.V. (AFMD) Buy Target $3.56 – Sell Target $5.68

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients […]

Read More
Biopharmaceuticals
Biotech
Stock Picks

These 2 Biotechs Could Be The Next Big Takeover Targets

Both have catalysts coming up that could make them prime candidates for a buyout.

Read More
Biopharmaceuticals
Biotech
Stock Picks

1 Stock That Could Double Your Money

This small but promising biotech recently had its U.S. debut and analysts say it could deliver a triple-digit return over the next twelve months.

Read More
Biopharmaceuticals
One Hot Stock
TradersPro Alerts

GT Biopharma, Inc. (GTBP) Buy Target $0.64 – Sell Target $1.70

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel immuno-oncology products based off its proprietary technology platforms. The company develops immuno-oncology product candidates, including OXS-1550, a bispecific scFv recombinant fusion protein-drug conjugate that targets cancer cells expressing the CD19 receptor or CD22 receptor, or both receptors; OXS-3550, a […]

Read More
Biopharmaceuticals
Biotech
Stock Picks

You’ve Never Heard Of This Biotech & Analysts Say It Could Surge 87% This Year

This biotech could see its first drug approved later this year, and it could send the stock skyrocketing.

Read More
Biopharmaceuticals
Pharmaceuticals
Stock Picks
Value Investing

2 Value Stocks That Are Stupid Cheap Right Now

Good bargains may be hard to come by right now, but these 2 stocks look ripe for the picking.

Read More
Biopharmaceuticals
One Hot Stock
TradersPro Alerts

Aeterna Zentaris Inc. (AEZS) Buy Target $4.35 – Sell Target $8.70

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology, endocrinology, and women’s health. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Can-Fite BioPharma Ltd. (CANF) Buy Target $1.17 – Sell Target $1.65

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company’s lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical […]

Read More